Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Jantra Grupo Indonesia Tbk. (KAQI) vs Organon Pharma Indonesia Tbk. (SCPI)

Jantra Grupo Indonesia Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Jantra Grupo Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Jantra Grupo Indonesia Tbk. diperdagangkan di Rp98 (kapitalisasi pasar 201,35 M, volume 24 jam 38,62 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Jantra Grupo Indonesia Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

KAQISCPI
Kapitalisasi Pasar
201,35 M104,4 M
Volume
38,62 jt
Lot
386,24 rb
Perputaran
3,75 M
Harga Rata-rata
97,02
Nilai Transaksi
3,75 M
Harga Ekuilibrium Indikatif
98
Volume Ekuilibrium Indikatif
16,32 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

KAQI
Lihat detail
SCPI
Lihat detail

Tentang Jantra Grupo Indonesia Tbk.

PT Jantra Grupo Indonesia Tbk (Company) was established on 26 September 2017 based on a Deed Notary No. 102 was made by Suhardi Hadi Santoso, S.H., Notary in Jakarta.

Selengkapnya di halaman KAQI

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI